BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17468189)

  • 1. Thyroid hormone deficiency and postmenopausal status independently increase serum osteoprotegerin concentrations in women.
    Botella-Carretero JI; Alvarez-Blasco F; San Millán JL; Escobar-Morreale HF
    Eur J Endocrinol; 2007 May; 156(5):539-45. PubMed ID: 17468189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
    Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Biondi B; Iorio S; Giustina A; Amato G; Carella C
    J Bone Miner Res; 2005 Mar; 20(3):480-6. PubMed ID: 15746993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study.
    Giusti M; Cecoli F; Fazzuoli L; De Franchis V; Ceresola E; Ferone D; Mussap M; Minuto F
    Metabolism; 2007 May; 56(5):699-707. PubMed ID: 17445547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of thyroid hormones on circulating markers of cell-mediated immune response, as studied in patients with differentiated thyroid carcinoma before and during thyroxine withdrawal.
    Botella-Carretero JI; Prados A; Manzano L; Montero MT; Escribano L; Sancho J; Escobar-Morreale HF
    Eur J Endocrinol; 2005 Aug; 153(2):223-30. PubMed ID: 16061828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum leptin in overt and subclinical hypothyroidism: effect of levothyroxine treatment and relationship to menopausal status and body composition.
    Teixeira PF; Cabral MD; Silva NA; Soares DV; Braulio VB; Couto AP; Henriques JL; Costa AJ; Buescu A; Vaisman M
    Thyroid; 2009 May; 19(5):443-50. PubMed ID: 19415994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs.
    Peterson ME; Melián C; Nichols R
    J Am Vet Med Assoc; 1997 Dec; 211(11):1396-402. PubMed ID: 9394888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma.
    Botella-Carretero JI; Gómez-Bueno M; Barrios V; Caballero C; García-Robles R; Sancho J; Escobar-Morreale HF
    Endocr Relat Cancer; 2004 Jun; 11(2):345-56. PubMed ID: 15163309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired action of thyroid hormone associated with smoking in women with hypothyroidism.
    Müller B; Zulewski H; Huber P; Ratcliffe JG; Staub JJ
    N Engl J Med; 1995 Oct; 333(15):964-9. PubMed ID: 7666915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased need for thyroxine in women with hypothyroidism during estrogen therapy.
    Arafah BM
    N Engl J Med; 2001 Jun; 344(23):1743-9. PubMed ID: 11396440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone turnover markers in patients with differentiated thyroid carcinoma after levothyroxine withdrawal.
    Gao YC; Gu Q; Liu QP; Ge WL; Lu HK
    Clin Lab; 2010; 56(3-4):87-93. PubMed ID: 20476639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of thyroid hormones on serum levels of adipokines as studied in patients with differentiated thyroid carcinoma during thyroxine withdrawal.
    Botella-Carretero JI; Alvarez-Blasco F; Sancho J; Escobar-Morreale HF
    Thyroid; 2006 Apr; 16(4):397-402. PubMed ID: 16646687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels.
    Martini G; Gennari L; De Paola V; Pilli T; Salvadori S; Merlotti D; Valleggi F; Campagna S; Franci B; Avanzati A; Nuti R; Pacini F
    Thyroid; 2008 Apr; 18(4):455-60. PubMed ID: 18399769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum leptin and ghrelin levels in premenopausal women with stable body mass index during treatment of thyroid dysfunction.
    Braclik M; Marcisz C; Giebel S; Orzeł A
    Thyroid; 2008 May; 18(5):545-50. PubMed ID: 18466078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kappaBeta ligand in patients under evaluation for differentiated thyroid carcinoma.
    Giusti M; Cecoli F; Ghiara C; Rubinacci A; Villa I; Cavallero D; Mazzuoli L; Mussap M; Lanzi R; Minuto F
    Hormones (Athens); 2007; 6(4):304-13. PubMed ID: 18055421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of substantial effects of raloxifene on thyroxine-binding globulin in postmenopausal women: dependency on thyroid status.
    Duntas LH; Mantzou E; Koutras DA
    Thyroid; 2001 Aug; 11(8):779-82. PubMed ID: 11525272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in plasma concentrations of osteoprotegerin before and after levothyroxine replacement therapy in hypothyroid patients].
    Xiang GD; Sun HL; Zhao LS; Hou J; Yue L
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2121-5. PubMed ID: 17988532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors related to clinical hypothyroid severity in thyroid cancer patients after thyroid hormone withdrawal.
    Huang SC; Wu VC; Lin SY; Sheu WH; Song YM; Lin YH; Wu CC; Chang WD
    Thyroid; 2009 Jan; 19(1):13-20. PubMed ID: 19072673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic stiffness and left ventricular function in patients with differentiated thyroid cancer.
    Gazdag A; Nagy EV; Erdei A; Bodor M; Berta E; Szabó Z; Jenei Z
    J Endocrinol Invest; 2015 Feb; 38(2):133-42. PubMed ID: 25194423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of serum thyrotropin (TSH) to the thyroid hormones after oral TSH-releasing hormone in patients with preclinical hypothyroidism.
    Staub JJ; Noelpp B; Gräni R; Gemsenjäger E; Hauenstein M; Girard J
    J Clin Endocrinol Metab; 1983 Mar; 56(3):449-53. PubMed ID: 6401757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary secretion of free alpha and beta subunit of human thyrotropin in patients with thyroid disorders.
    Kourides IA; Weintraub BD; Ridgway EC; Maloof F
    J Clin Endocrinol Metab; 1975 May; 40(5):872-85. PubMed ID: 1127093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.